ghk-cu hair growth evidence studies GHK Peptide Clinical Trial (2016) — Research Summary ghk-cu hair growth evidence clinical

SIRT1s ability to deacetylate and thereby activate key proteins involved in ferroptosis, such as GPX4 and FOXO3A, positions it as a nodal point in the regulation of this cell death process

GHK-Cu has demonstrated anti-inflammatory properties in multiple research settings

This process is influenced by androgens (male hormones)

Oral Dosing Runs Higher Injectable: 200 to 500mcg per dose Oral: 500 to 1,000mcg per dose, once or twice daily, taken on an empty stomach Higher oral doses are used to make up for the fact that the gut absorbs the compound poorly compared to injections

Start with twice weekly evening application